California Inflammatory and Rare Retinal Diseases

Are you looking for an inflammatory and rare retinal disease specialist in California?

At Retina Associates of Orange County, we provide care for inflammatory and rare retinal diseases recognized by the American Society of Retina Specialists and delivered to patients throughout California.

If you have been diagnosed with an inflammatory eye condition, are experiencing unexplained vision changes alongside joint pain, skin rashes, or other systemic symptoms, or have been told you have a rare retinal disease that your general ophthalmologist is not equipped to manage, a fellowship-trained retinal specialist can help. Our physicians at Retina Associates of Orange County are board-certified by the American Board of Ophthalmology and have treated complex inflammatory and rare retinal conditions for more than 23 years. Our California inflammatory and rare retinal diseases specialist can provide the diagnostic precision these conditions require. Contact our office to schedule an evaluation.

Inflammatory and Rare Retinal Disease Specialist in California

Inflammatory retinal diseases occur when the immune system attacks the tissues of the eye, causing swelling, redness, pain, and vision loss. Rare retinal diseases include a broad spectrum of genetic and autoimmune conditions that affect a small percentage of the population but carry significant consequences for vision. Both categories require a retinal specialist with the diagnostic tools and clinical experience to manage them properly.

According to the NEI uveitis page, uveitis is one of the most common inflammatory eye conditions and can cause vision loss if left untreated. California’s large and ethnically diverse population increases the likelihood that physicians here will encounter the full range of autoimmune and inflammatory retinal diseases, including conditions like Vogt-Koyanagi-Harada disease, Behçet’s disease, and sarcoidosis-related eye inflammation. A retina specialist who treats these conditions regularly is essential to achieving accurate diagnosis and preserving long-term vision.

Inflammatory and Rare Retinal Disease Services We Offer in California

Retina Associates of Orange County provides comprehensive evaluation and treatment for inflammatory and rare retinal diseases from our offices in Laguna Hills, CA, Newport Beach, and Santa Ana. Our physicians use advanced retinal imaging, laboratory coordination, and multidisciplinary collaboration to manage conditions that often involve both the eye and the broader immune system.

• Uveitis evaluation and management. Uveitis refers to inflammation of the uveal tract, which includes the iris, ciliary body, and choroid. Our physicians diagnose and treat all forms of uveitis, including anterior, intermediate, posterior, and panuveitis, and coordinate with rheumatologists and immunologists when a systemic cause is identified.
• Retinal vasculitis assessment. Inflammation of the retinal blood vessels can lead to vascular leakage, ischemia, and vision loss. Retinal vasculitis is frequently associated with systemic autoimmune diseases, and our evaluation includes fluorescein angiography, OCT, and laboratory studies to identify the underlying condition.
• White dot syndrome diagnosis. White dot syndromes are a group of rare inflammatory conditions that produce characteristic lesions on the retina and choroid. Conditions like multifocal choroiditis, birdshot chorioretinopathy, and acute posterior multifocal placoid pigment epitheliopathy each require a specific diagnostic approach and management strategy.
• Corticosteroid and immunomodulatory therapy. Many inflammatory retinal diseases are managed with intravitreal or periocular corticosteroid injections to reduce swelling quickly. When long-term suppression is needed, our physicians coordinate systemic immunosuppressive therapy with the patient’s rheumatologist or internist.
• Anti-VEGF injection therapy. Inflammatory conditions can trigger abnormal blood vessel growth or macular edema. Anti-VEGF medications are used alongside anti-inflammatory treatment to stabilize vision and prevent structural damage to the retina.
• Optical coherence tomography. OCT imaging plays a central role in monitoring inflammatory retinal diseases. It detects macular edema, subretinal fluid, and structural changes that may not be visible during a standard examination, allowing physicians to adjust treatment in response to objective data.
• Inherited retinal diseases. Genetic retinal conditions such as retinitis pigmentosa, Stargardt disease, and cone-rod dystrophy fall under the rare disease category. Our physicians provide diagnostic evaluation, genetic counseling referrals, and ongoing monitoring for patients with these progressive conditions.
• Diagnostic vitrectomy. In cases where the cause of intraocular inflammation remains unclear after noninvasive testing, a vitrectomy may be performed to obtain a tissue sample for laboratory analysis. This procedure can help distinguish infectious from noninfectious causes and guide targeted treatment.

Why Choose Retina Associates of Orange County for Inflammatory and Rare Retinal Diseases in California?

Academic Affiliations and Research Background

Inflammatory and rare retinal diseases present diagnostic challenges that benefit from physicians with strong academic ties and research backgrounds. Dr. Mrinali Gupta has authored more than 80 peer-reviewed research publications in retina. She serves on the Board of Directors of the American Society of Retina Specialists and co-chairs the ASRS Early Career Section. She trained at Duke, completed her residency at Harvard’s Massachusetts Eye and Ear Infirmary, and finished her fellowship at Weill Cornell. Her published work and leadership positions reflect direct engagement with the evolving standards of care for complex retinal conditions.

Dr. John Lean studied medicine at Oxford University and completed his ophthalmology residency and vitreoretinal fellowship at Moorfields Eye Hospital in London. He is a Fellow of the Royal College of Surgeons and holds membership in the Retina Society, the Macula Society, and Club Jules Gonin. Dr. Lean has been honored with numerous visiting professorships worldwide. Our clinical trials program also gives patients access to investigational therapies that may not yet be widely available.

Coordinated Care for Complex Conditions

Inflammatory and rare retinal diseases rarely affect the eye in isolation. Conditions like sarcoidosis, Behçet’s disease, and Vogt-Koyanagi-Harada often involve multiple organ systems and require coordination between retinal specialists, rheumatologists, immunologists, and internists. Our retinal specialist practice is structured to facilitate that coordination, with detailed imaging reports and treatment summaries shared directly with each patient’s care team. We maintain offices in Laguna Hills, Newport Beach, and Santa Ana so that patients with chronic conditions requiring frequent monitoring can be seen without burdensome travel.

Understanding Inflammatory and Rare Retinal Disease Care

Conditions We Treat and Treatment Options

Inflammatory and rare retinal diseases span a wide range of conditions with different causes, presentations, and treatment approaches. Some are driven by autoimmune dysfunction, others by infection, and some remain idiopathic. The following conditions represent the most common reasons patients are referred to our practice for inflammatory and rare retinal disease care:

• Posterior uveitis and panuveitis, including cases associated with autoimmune disease
• Retinal vasculitis, which may accompany lupus, sarcoidosis, or Behçet’s disease
• White dot syndromes such as birdshot chorioretinopathy, multifocal choroiditis, and serpiginous choroidopathy
• Vogt-Koyanagi-Harada disease, an autoimmune condition that affects the eyes, skin, and nervous system
• Sarcoidosis-related ocular inflammation
• Infectious retinitis, including toxoplasmosis and viral retinitis
• Genetic retinal dystrophies, including retinitis pigmentosa and Stargardt disease

Treatment is individualized. Acute inflammation may be controlled with intravitreal corticosteroid injections, while chronic or recurrent disease often requires systemic immunosuppressive agents managed in coordination with a rheumatologist. Anti-VEGF therapy is used when inflammation leads to secondary neovascularization or macular edema. For genetic conditions, the focus shifts to monitoring progression, maximizing remaining vision, and exploring eligibility for clinical trials. Recognizing early warning signs is critical, as delayed treatment in inflammatory retinal disease can lead to irreversible structural damage.

What Should You Expect from Treatment?

• A comprehensive dilated examination of both eyes, with particular attention to signs of inflammation, vascular leakage, and structural damage
• Advanced imaging including OCT, fluorescein angiography, and indocyanine green angiography to map the extent and activity of disease
• Laboratory testing to evaluate systemic autoimmune markers, infectious causes, and organ involvement
• A multidisciplinary discussion of findings and a treatment plan developed in coordination with your other physicians when applicable
• Ongoing adjustments to therapy based on imaging data, symptom changes, and laboratory results

What Is the Typical Treatment Timeline?

• Your first visit includes a comprehensive evaluation with multiple imaging studies and typically lasts 90 minutes or longer
• Laboratory results may take several days to return, and your physician will contact you to discuss findings and next steps
• If intravitreal injections are indicated, treatment may begin at your first or second visit
• During active inflammation, follow-up visits are typically scheduled every two to four weeks until the disease is controlled
• Once inflammation is stable, monitoring visits are spaced to every two to three months, with adjustments based on individual response
• Timelines vary significantly based on the specific diagnosis, severity of inflammation, and whether systemic immunosuppressive therapy is required

What Should You Bring to Your First Visit?

• Insurance card and photo ID
• A complete list of all current medications, including immunosuppressants, biologics, and corticosteroids
• Medical records, lab results, and imaging from your rheumatologist, immunologist, or referring ophthalmologist
• A written summary of your medical history, including any diagnosed autoimmune conditions, infections, or systemic illnesses
• Questions about your diagnosis, treatment options, and how care will be coordinated among your physicians

Patients referred for inflammatory or rare retinal disease evaluation should expect a longer initial appointment than a routine eye exam. The complexity of these conditions requires detailed imaging, careful documentation, and often coordination with outside specialists before a treatment plan is finalized.

What Are Some Important California Resources for Inflammatory and Rare Retinal Diseases?

Patients seeking information about inflammatory and rare retinal diseases or physician credentials in California can consult the following:

• The National Eye Institute provides guides on uveitis, retinitis pigmentosa, rare eye diseases, and available clinical trials across the United States
• The CDC vision health initiative tracks eye disease prevalence and publishes data on vision loss prevention at the national and state level
• The Medical Board of California allows patients to verify a physician’s license status, board certifications, and disciplinary history
• The American Academy of Ophthalmology publishes patient education materials on uveitis, autoimmune eye disease, and retinal inflammatory conditions
• The American Society of Retina Specialists offers a fellowship-trained physician directory for patients seeking subspecialty retinal care

These resources are informational and should not replace a clinical evaluation. Patients experiencing symptoms of an inflammatory or rare retinal disease should seek care from a qualified retinal specialist rather than delaying evaluation.

Contact Retina Associates of Orange County

Inflammatory and rare retinal diseases are among the most complex conditions in ophthalmology. If you have received a new diagnosis, are experiencing worsening vision despite treatment, or need a second opinion from a fellowship-trained retinal specialist, Retina Associates of Orange County can help.

Your first appointment will include advanced retinal imaging, a thorough examination, and a detailed conversation with your physician about diagnosis and treatment. We accept most major insurance plans and Medicare, and our offices in Laguna Hills, Newport Beach, CA, and Santa Ana, CA are equipped to handle the diagnostic demands of inflammatory and rare retinal conditions. Contact us to schedule your evaluation.